Texas HB4586 prohibits direct-to-consumer pharmaceutical advertising and allows for administrative penalties.

Texas HB4586 amends the Health and Safety Code to prohibit direct-to-consumer pharmaceutical advertising, including through television, radio, print media, digital platforms, and social media. The bill defines direct-to-consumer pharmaceutical advertising as any promotional communication targeting consumers that markets prescription drugs. The Texas Department of State Health Services may assess an administrative penalty against violators, with a maximum penalty of $10,000 per day for each violation. Each day a violation continues may be considered a separate violation.

Texas HB4586 prohibits direct-to-consumer pharmaceutical advertising and allows for administrative penalties.

Texas HB4586 amends the Health and Safety Code to prohibit direct-to-consumer pharmaceutical advertising, including through television, radio, print media, digital platforms, and social media. The bill defines direct-to-consumer pharmaceutical advertising as any promotional communication targeting consumers that markets prescription drugs. The Texas Department of State Health Services may assess an administrative penalty against violators, with a maximum penalty of $10,000 per day for each violation. Each day a violation continues may be considered a separate violation.